Livensa União Europeia - sueco - EMA (European Medicines Agency)

livensa

warner chilcott  deutschland gmbh - testosteron - sexuella dysfunktioner, psykologiska - könshormoner och modulatorer av könsorganen, - livensa är indicerat för behandling av hypoaktiv sexuell ledsjukdom (hsdd) vid bilateralt oophorektomiserad och hysterektomiserad (kirurgiskt inducerad klimakterium) kvinnor som får samtidig östrogenbehandling.

Plerixafor Accord União Europeia - sueco - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunstimulatorer, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Vildagliptin Accord 50 mg Tablett Suécia - sueco - Läkemedelsverket (Medical Products Agency)

vildagliptin accord 50 mg tablett

accord healthcare b.v. - vildagliptin - tablett - 50 mg - laktos (vattenfri) hjälpämne; vildagliptin 50 mg aktiv substans

Suprefact Depot 9,45 mg Implantat Suécia - sueco - Läkemedelsverket (Medical Products Agency)

suprefact depot 9,45 mg implantat

orifarm ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin

Suprefact Depot 9,45 mg Implantat Suécia - sueco - Läkemedelsverket (Medical Products Agency)

suprefact depot 9,45 mg implantat

orifarm ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin

Suprefact Depot 9,45 mg Implantat Suécia - sueco - Läkemedelsverket (Medical Products Agency)

suprefact depot 9,45 mg implantat

orifarm ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin

Suprefact Depot 9,45 mg Implantat Suécia - sueco - Läkemedelsverket (Medical Products Agency)

suprefact depot 9,45 mg implantat

orifarm ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin

Suprefact Depot 9,45 mg Implantat Suécia - sueco - Läkemedelsverket (Medical Products Agency)

suprefact depot 9,45 mg implantat

paranova läkemedel ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin

Cipralex 10 mg Filmdragerad tablett Suécia - sueco - Läkemedelsverket (Medical Products Agency)

cipralex 10 mg filmdragerad tablett

orifarm ab - escitalopramoxalat - filmdragerad tablett - 10 mg - escitalopramoxalat 12,77 mg aktiv substans - escitalopram

Cipralex 10 mg Filmdragerad tablett Suécia - sueco - Läkemedelsverket (Medical Products Agency)

cipralex 10 mg filmdragerad tablett

parallell pharma ab - escitalopramoxalat - filmdragerad tablett - 10 mg - escitalopramoxalat 12,77 mg aktiv substans - escitalopram